Biocatalysis and metabolic engineering seeks to control the complex interplay and regulation of multi-enzyme processes to perform complex chemical reactions that can produce costly or difficult to manufacture substances.

Research is aimed at understanding and taking advantage of natural metabolic processes found in cellular pathways for chemical transformation, energy transfer, and supramolecular construction. This technology has become increasingly important to chemical and pharmaceutical companies.

Particular focus for Rensselaer scientists is in pharmaceutical and nanoscience applications of biocatalysis and metabolic engineering.

Robert J. Linhardt, Ph.D., the Ann and John H. Broadbent, Jr. '59 Senior Constellation Professor, provides research leadership in biocatalysis and metabolic engineering.

Back to Center Research